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Abstract: Otitis media (OM) is one of the most common diseases occurring during childhood.
Microbiological investigations concerning this topic have been primarily focused on the four
classical otopathogens (Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and
Streptococcus pyogenes) mainly because most of the studies have been conducted with culture-dependent
methods. In recent years, the introduction of culture-independent techniques has allowed
high-throughput investigation of entire bacterial communities, leading to a better comprehension
of the role of resident flora in health and disease. The upper respiratory tract (URT) is a region of
major interest in otitis media pathogenesis, as it could serve as a source of pathogens for the middle
ear (ME). Studies conducted with culture-independent methods in the URT and ME have provided
novel insights on the pathogenesis of middle ear diseases through the identification of both possible
new causative agents and of potential protective bacteria, showing that imbalances in bacterial
communities could influence the natural history of otitis media in children. The aim of this review is to
examine available evidence in microbiome research and otitis media in the pediatric age, with a focus
on its different phenotypes: acute otitis media, otitis media with effusion and chronic suppurative
otitis media.
Keywords: otitis media; microbiota; upper respiratory tract; adenoid; middle ear; microbiota axes
1. Introduction
The human microbiota consists of ecological communities of commensal, symbiotic and pathogenic
microorganisms that colonize several body sites, as the gastrointestinal tract, respiratory system, oral
cavity, skin and female reproductive system [1]. In past years, microbiological investigations have been
predominantly conducted with culture-dependent methods, therefore many sites in the human body
have been considered sterile until recently. However, the introduction of culture-independent
techniques has allowed investigation of entire bacterial communities [2], leading to a better
comprehension of the role of resident flora in health and disease. These microorganisms and
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their products play indeed a critical role in the regulation of many homeostatic processes, including
immune response and inflammation [3] and defense against pathogens [4]. A diseased alteration
in the composition of these bacterial communities, defined dysbiosis, can therefore lead to many
pathological conditions, including infections [5].
Most of these studies have been conducted with a marker gene analysis based on a broad-range
PCR, using primers that target a segment of the 16SrRNA gene, a highly conserved region contained
in bacterial genomes. This method, combined with next-generation sequencing technologies, permits
the simultaneous characterization of an entire community [6]. This approach allows a fast and
cost-effective analysis that provides a low-resolution view of a microbial community. However, there
are also some limitations that should be taken into account when interpreting data derived from these
studies: it is not possible to determine whether taxa detected are alive or dead, active or inactive, thus
there is limited functional information; it is susceptible to over amplification bias, especially with
low biomass samples such as middle ear fluid; as a short segment of 16SrRNA gene is amplified and
sequenced, taxonomic resolution is usually limited to family or genus level; there is great variability
depending on technical aspects as region selection, amplicon size, sampling, storage, sequencing
approach, and bioinformatic analysis. Full-gene 16S rRNA gene sequencing and metagenome and
metatrascriptome analyses may overcome some of these limitations but are less adopted as they are
relative expensive and complex to perform [7]. Middle ear infections and diseases are widespread
in pediatric age. Acute otitis media (AOM) is the most common bacterial infection in childhood [8]
and the leading cause of antibiotic prescription in pediatric patients [9]; similarly, otitis media with
effusion (OME) is prevalent in the first years of life, as up to 80% of children suffer from one or more
episodes by 10 years of age; however, it should be considered that the prevalence of OME varies across
population and could be difficult to define accurately, as this condition is often asymptomatic [10].
The upper respiratory tract (URT) is a region of major interest in otitis media pathogenesis:
According to the Pathogen Reservoir Hypothesis (PRH), the adenoid pad serves as a source of
pathogens that can grow in this region and further spread to the respiratory system and middle ear,
leading to infections and diseases [11–14].
The URT extends from the nostrils to the portion of the larynx above the vocal cords and harbors
the highest bacterial density in the whole respiratory system [15]; however, these bacterial communities
have been studied with more effort and from an ecological perspective only in recent years, after
the introduction of culture-independent techniques [16].
Scientific interest has been focused on the comprehension of the characteristics of a healthy
URT microbiota and the mechanism that guarantees its balance, as mounting evidence shows that
resident bacteria are able to inhibit colonization and growth of otopathogens [14,17,18]. Those
microorganisms that are essential in maintaining balance and function of a bacterial community are
defined keystone species (see Table 1 for definitions of common terms used in microbiota analysis).
In the URT, Dolosigranulum spp. and Corynebacterium spp. have been identified as potential keystone
species, as they have been associated with respiratory health and exclusion of otopathogens in several
studies [19–22].
Reconstitution of healthy microbial communities through administration of probiotics for
the prevention of middle ear diseases in children is a topic of major clinical and scientific interest.
Several trials have been conducted, but results lack consistency [23,24]. Deepening our knowledge
on the physiological features of the URT microbiota and understanding how modifications in its
balance relate to the pathogenesis of otitis media could be of remarkable importance in developing
probiotic therapies. Furthermore, middle ear microbiota involvement in this field has been gaining
interest in recent years, although less studies are available in comparison with URT microbiota, due to
the different feasibility in collecting samples.
The aim of this review is to examine evidence available in microbiome research on otitis media
in children. We will describe the most important factors that impact on microbiota development
in the first years of life and that could influence the natural history of otitis media; then, we will
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focus on otitis media phenotypes and discuss evidence available on URT and middle ear microbiome
in different diseases.
Table 1. Definitions of common terms used in microbiota investigations.
Microbiota
Ecological communities of commensal, symbiotic and pathogenic
microorganisms that colonize several body sites, as the gastrointestinal
tract, respiratory system, oral cavity, skin, and female reproductive system
Microbiome Genetic material of the microorganisms of a community
Keystone Species Microorganisms with a great impact on an ecological community,considered important in maintaining its organization and function
Biodiversity
Number of OTUs in a community and their relative abundance. It is
determined by richness (how many OTUs in a sample?) and evenness
(how equally distributed relative abundances are in a sample?)
Alpha-Diversity Diversity within sample: how abundant OTUs are in relation to othersin the same sample?
Beta-Diversity Measure that compares different microbial communities
Operational Taxonomic Unit (OTU) Cluster of related sequences (usually with 97% or more similarity) thatrepresent a taxonomic unit of a microorganism
2. Methods
The research was conducted on the PubMed database, including all evidences available until April
2020. MeSH terms as “otitis media”, “microbiota”, “child”, “child, preschool” and “infant” were used.
More articles were included combining the keywords “microbiota” and “microbiome” with terms as
“acute otitis media”, “otitis media with effusion”, “chronic otitis media”, “adenoid”, “adenotonsillar”,
“nasopharyngeal”, “middle ear”.
A total of 91 potentially relevant studies were identified through this search strategy. After title
and abstract analysis, 51 studies were excluded as non-pertinent, according to the following criteria:
disease different from OM; site of investigation different from URT or ME; adult population; studies
conducted on animals were also excluded, as the main focus of this review was to discuss evidence
available in children. A total of 40 remaining articles were then selected for more detailed assessment,
and 14 investigations were further excluded in this phase (see Figure 1 for more details on methods).
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Figure 1. Search strategy conducted for this review. Legend: OM: Otitis media. AOM: Acute otitis
media. OME: Otitis media with effusion. CSOM: Chronic suppurative otitis media. ME: Middle Ear.
URT: Upper respiratory tract.
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After this process, 26 studies were included in this review: 10 studies on acute otitis media (AOM,
1321 subject enrolled in all studies), 13 studies on otitis media with effusion (OME, 501 subjects enrolled
in all studies), 3 studies on chronic suppurative otitis media (CSOM, 217 subjects enrolled in all studies).
3. Environmental Factors and Microbiota Development in the First Years of Life
The microbial communities that colonize the human organism are dynamic and change throughout
life under the effect of several environmental factors, but infancy and early childhood represent
the critical period in shaping their composition [25,26]. These external factors can impair the homeostatic
functions mediated by the microbiota, leading to immediate consequences or impacting the health
status in the later stages of life [27]. This is particularly evident for the URT microbiota, as this region
is interconnected with middle ear, lower respiratory tract, and gastrointestinal tract, and represents
the interface between these systems and the external environment.
Immediately after birth, in the first hours of life, the URT in healthy neonates becomes colonized
by microorganisms of maternal origin [28]. Niche differentiation starts in the first week of life, with
a predominance of Staphylococcus spp., followed by an enrichment of Corynebacterium, Dolosigranulum,
and Moraxella [29].
The first months of life are of remarkable importance in the development of URT microbial
communities and their composition: Biesbroek et al. described eight distinct microbiota profiles
in the URT of healthy infants, showing that a distinct bacterial profile could be identified by the sixth
week of life; moreover, this early bacterial colonization plays a pivotal role in the stability of microbial
communities: profiles dominated by Moraxella and Dolosigranulum/Corynebacterium are associated with
a stable microbiota and with lower rates of respiratory infections in later stages of life, while less stable
profiles are associated with high abundance of Haemophilus and Streptococcus [30].
Theo et al. confirmed the role of Corynebacterium and found a positive role of Alloiococcus
in the first year of life in the development of URT microbial communities; moreover, authors reported
data on nasopharyngeal (NP) microbiota in children with respiratory diseases, concluding that some
Moraxella spp. were associated with an increased risk of disease rather than respiratory health [31].
Several environmental factors, discussed below, can influence the shaping of the URT microbiota
composition in the first years of life.
3.1. Delivery Route
As it is generally known, children born by caesarian-section (C-section) suffer from a higher incidence
of respiratory illness and morbidity in comparison with children born by vaginal delivery [32,33].
In one of the first reports concerning nasopharyngeal microbiota and route of delivery, swabs
from different body sites were collected from healthy neonates immediately after birth: Authors found
that undifferentiated microbial communities in vaginally delivered children were similar to maternal
vaginal microbiota, while those who were born by C-section had microbial communities resembling
maternal skin surface [28].
A subsequent longitudinal study on this theme analyzed nasopharyngeal swabs collected from
102 children in the first 6 months of life, showing a predominance of bacteria previously associated
to microbiome stability and respiratory health in early stages of life (Moraxella, Corynebacterium,
and Dolosigranulum) in children born by vaginal delivery [29]. These microorganisms are likely derived
from maternal skin (Staphylococcus and Corynebacterium) [34] or from vaginal tract (Dolosigranulum,
Staphylococcus, or Streptococcus) [35].
However, by contrast, another study evidenced that differences related to delivery route are
transient and disappear by six weeks of age, suggesting that the development of the microbiota
in the postnatal period is more related to the body site that harbors a community [36].
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3.2. Breastfeeding
Breastfeeding is a significant protective factor against infections [37,38]. This effect is related not
only to the presence of antibacterial substances in maternal milk [39], as it is known that breastfeeding
can significantly facilitate the development of a healthy microbiota.
Biesbroek et al. showed that breastfed infants develop a bacterial profile enriched by Dolosigranulum
and Corynebacterium at six weeks of age in comparison with formula fed infants; moreover,
Dolosigranulum abundance was inversely associated with wheezing episodes and a number of parental
reported respiratory tract infections, even after correction for feeding type. [40].
Similar data were provided by Bosch et al.: Children who suffered from a higher number of
respiratory infections had an aberrant nasopharyngeal microbiota development in the first month
of life, that coincided with a prolonged reduction of Dolosigranulum and Corynebacterium; authors
found that breastfeeding was an independent driver of this aberrant development, as a prolonged
dominance of these bacteria was observed in breastfed infants. However, similarly to delivery route,
these dissimilarities are transient and disappear around six months of age [41].
3.3. Antibiotic Therapy
Antibiotic therapy can significantly impair composition and balance of the microbiome [42].
This is particularly relevant in pediatric age, in which antibiotic prescription and misuse is quite
common [43].
In the URT, antibiotic administration causes a reduction of the abundance of potential beneficial
bacteria, such as Dolosigranulum and Corynebacterium, and an increase in Haemophilus, Streptococcus,
and Moraxella [31]. Moreover, in children with AOM, a recent antibiotic therapy induces a reduction
of Streptococcaceae and Corynebacteriaceae and an increased abundance of Enterobacteriaceae and
Pasturellaceae in the URT [44]. Subsequent longitudinal studies confirmed how antibiotic treatment
can induce a reduction in the abundance of potential beneficial bacteria, as Dolosigranulum and
Corynebacterium [41,45].
3.4. Pneumococcal Vaccination
The introduction of the pneumococcal conjugate vaccination (PCV) in the pediatric population
has led to an important reduction of OM episodes caused by the serotypes included in the vaccine [46].
On the other hand, the introduction of pneumococcal vaccination programs has resulted in important
modifications in OM microbiology: H. influenzae has become the most common otopathogen and
OM episodes caused by M. catarrhalis have become more frequent; moreover, serotypes not included
in PCVs have been more frequently identified as causative agents of diseases [47,48].
These findings suggest that the introduction of PCVs might have induced modifications
in the composition of the microbial communities in the respiratory system. However, evidence
supporting these findings has been focused prevalently on otopathogens, while studies conducted
with high-throughput methods and looking at whole bacterial communities in the URT are lacking
and show conflicting results.
In one of the first investigations on the whole NP microbiota and AOM, Hilty et al. reported
that a previous exposure to PCV-7 in children with AOM was associated with reduced abundance of
commensal families (Streptococcaceae and Corynebacteriaceae) [44].
A possible influence of this vaccination on NP microbiota was later reported by Biesbroek et al.
In this investigation, NP swabs were collected from healthy children who received PCV-7 and from
unvaccinated children: vaccination affected the URT microbiota causing a shift in composition and
structure of the bacterial community, with an increase of Veillonella, Prevotella, Fusobacterium, Leptotrichia,
Actinomyces, Rothia, and non pneumococcal streptococci, in addition to an increased bacterial diversity
and inter-individual variability [49].
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Longitudinal data on this theme were further provided in another study conducted in Switzerland
by Mika et al., who compared NP microbiota in healthy children who were vaccinated with PCV-7 or
PCV-13, showing that those who received PCV-13 had a more diverse and stable URT microbiota and
a lower pneumococcal carriage rate compared to those who received PCV-7 [50].
However, in contrast to these findings, other available studies suggest that PCV might not have
such a relevant impact on the URT microbiota. Faezel et al. performed a randomized controlled trial
in Kenya comparing NP microbiota of children who received a 10-valent pneumococcal vaccine vs.
children who received Hepatitis A vaccine. In this longitudinal study, NP swabs were collected before
the administration of the vaccine and after 6 months. The authors found that PCV did not cause any
significant alteration in the abundance or prevalence of otopathogens [51].
Moreover, a more detailed longitudinal study conducted in Gambia analyzed NP swabs collected
periodically from birth to the first year of life. Children were divided in three groups according to
vaccination schedule: Two groups received two different types of PCV-7, while the third group was
composed by unvaccinated children. Again, bacterial communities were comparable across groups,
as there were no significant differences in richness, diversity, and composition. Interestingly, PCV-7
vaccination reduced the nasopharyngeal carriage of vaccine serotypes, but pneumococcal carriage
remained high among vaccinated infants, probably because of an immediate expansion of non-vaccine
serotypes [52].
Interesting data were provided by Andrade et al. in a complex investigation that compared
53 children vaccinated with PCV-10 vs. 27 unvaccinated children. The strength of this study is
the integrated metagenomic and transcriptomic analysis: no difference were found in nasopharyngeal
carriage rates of S. pneumoniae, S. aureus, H. influenzae, or M. catarrhalis by either transcriptomic
ormetagenomics analysis, but unvaccinated children had higher metabolic rates for S. pneumoniae,
compared to PCV-10 vaccinated children [53].
Available evidence thus suggest that PCV has a direct impact on pneumococcal carriage, which
in turn might indirectly affect the whole bacterial community in the URT. However, results are
conflicting: a possible explanation could be found in the variation of pneumococcal carriage rates
in relation to the geographic region and socio-economic status: the effects of PCV might indeed be
different while considering developed or developing countries [54].
This particular theme was investigated in a study conducted in Fiji, in which NP microbiota from
two ethnic groups (iTaukei and Fijians of Indian descent) was analyzed. These groups are known to
have a different carriage prevalence of S. pneumoniae and a different burden of pneumococcal disease,
which is higher in the iTaukei population. NP swabs were collected from 132 total children belonging
to the two ethnic groups that were further divided in two subgroups based on whether children had
been previously vaccinated or not with PCV-7. The vaccination had no overall impact on microbial
diversity or composition, but significant modifications were evident when stratifying by ethnicity:
vaccinated iTaukei children had a lower relative abundance of Streptococcus and Haemophilus compared
with unvaccinated ones, while vaccinated Indian descent children had a higher relative abundance of
Dolosigranulum compared with those unvaccinated [55].
3.5. Smoking
Studies conducted in adult subjects suggest that active smoking impairs URT microbiota
composition [56]. It is likely that similar effects involve the pediatric population; however, studies
concerning active and passive smoking effects on URT microbiome in children are lacking.
4. Acute Otitis Media
Acute otitis media (AOM) is defined by the presence of fluid in the middle ear associated to signs
and symptoms of acute infection. It affects the majority of children in the first 3 years of life and
becomes recurrent in almost 50% of cases [10]. Recurrent acute otitis media (RAOM) is defined as four
or more AOM episodes in one year or three or more episodes in 6 months [57].
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Laufer et al. performed one of the first studies comparing NP microbiome in children with
AOM to healthy children. The authors evidenced that a higher relative abundance of Corynebacterium
and Dolosigranulum, in addition to Propionibacterium, Lactococcus, and Staphylococcus, was associated
with a lower incidence of pneumococcal colonization and AOM. The same study showed that a less
diverse and a less even microbiota was associated with colonization by S. pneumoniae, highlighting
the correlation between a higher biodiversity and better outcomes [20].
These data were confirmed in a subsequent investigation conducted by the same group on
240 children aged 6 months–3 years, that evidenced that a lower biodiversity was associated with
a higher colonization rate not only from S. pneumoniae but also from H. influenzae and M. catharralis;
moreover, authors compared diversity indices between health status and during an acute upper
respiratory infection (URTI), showing that biodiversity was significantly higher in healthy children
than during disease [19].
These findings on biodiversity during URTI are coherent with data provided by Hilty et al. that
evidenced how NP bacterial density is lower in children during an AOM episode compared with
the same in healthy status. Moreover, interesting insights were provided on how the infants’ microbiota
undergoes changes during an AOM episode, as the classical otopathogens predominated over
commensal families (Staphylococcaceae, Flavobacteriaceae, Carnobacteriaceae, and Comamonadaceae) [44].
In 2017 Chonmaitree et al. performed a longitudinal study on 139 healthy neonates, followed
since birth for the first 12 months of life or until the occurrence of the first AOM episode, collecting
971 swabs performed monthly and during an URTI or AOM. In particular, as it is known that URTI
often precedes an AOM episode, authors studied the characteristics of the NP microbiome during
transitional phase from URTI to AOM. Data revealed that an unstable microbiota during an URTI
episode with the predominance of otopathogens were associated with the occurrence of symptomatic
viral infection and with a higher risk of transition from URTI to AOM. Interestingly, otopathogens
were not predominant during otherwise asymptomatic viral infections [45].
Evidence on otitis-prone children, i.e., those already suffering for RAOM were provided by
Dirain et al.: Authors compared the microbial flora on adenoid tissue in a small group of subjects
undergoing adenoidectomy for RAOM (n = 5) or obstructive sleep apnea (OSA) (n = 5), finding that
the relative abundance of S. pneumoniae and M. catharralis was higher in the RAOM group [58].
A complex study with a higher sample size was subsequently performed on an Australian
population, comparing NP microbiome of 103 healthy children vs. 93 otitis-prone children undergoing
grommet insertion for RAOM, in order to identify potential protective genera. This investigation
confirmed the pivotal role of Dolosigranulum and Corynebacterium in NP microbiome, as these two
genera have been found to be significantly more abundant in the NP of healthy children compared
with otitis-prone children. As for biodiversity, in contrast with previous findings, this study found that
otitis-prone children had a significantly more diverse microbiome than controls. In addition, authors
analyzed middle ear fluid (MEF) microbiome collected from children undergoing surgery from RAOM
and performed a paired comparison with the NP microbiome of the same subject. Results showed that
these two niches were not highly concordant: In particular, the interesting data is that Alloiococcus and
Turicella have been found to be abundant in MEF but almost absent in the NP [22].
The MEF microbiome during an AOM episode was further investigated on 79 subjects aged
5–42 months. This report confirmed that the classical otopathogens are the predominant species in MEF
during AOM: S. pneumoniae was dominant in 16% of samples, H. influenzae in 17%, and M. catarrhalis
in 5.6%; moreover, Turicell aotitidis was detected as a clearly dominant bacteria in two samples,
suggesting that it could be a rare but true causative agent; Alloiococcus otitidis was detected only
in 3 samples; Staphylococcus auricolaris was predominant in two samples, but authors speculated
that this finding could be related to potential contamination from the external auditory canal (EAC);
however, A. otitidis and T. otitidis could be also related to EAC contamination [59].
Xu et al. compared the MEF microbiota during AOM episode to the NP microbiota analyzed
on nasal wash (NW) samples: A significantly higher abundance of A. otitidis was detected in MEF
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during AOM, compared with NW in health and disease; authors concluded that the ME could harbor
a resident microbiome that becomes different from NP after the onset of an infection. Moreover,
NP microbiome was analyzed prior to the onset of AOM vs. at AOM onset: In line with previous data,
NP microbiome during health was significantly more diverse than during AOM [60].
Paired analysis of NP and MEF microbiome during an AOM episode was subsequently performed
on a larger population, collecting 286 NP swabs in children aged 0–6 years; 42/286 episodes were
characterized by spontaneous tympanic membrane perforation (STMP), and thus, MEF microbiome
was analyzed in these cases. Authors found that diversity was strictly related to age: in particular, older
children had a higher richness and showed more personalized bacterial profiles, that develop toward
the end of the sixth year of life. The transition to an adult-like microbiome appeared in children older
than 3 years and was defined by an increase in Staphylococcaceae and Corynebacteriaceae. Furthermore,
authors found concordance between NP and MEF microbiome when the predominant bacteria in MEF
was S. pyogenes, H. influenzae, or S. pneumoniae. However, even this event appeared to be age-related,
as the concordance between NP and MEF microbiome became weaker as children got older. Authors
thus concluded that the NP microbiota does not necessarily resembles the one in ME: The URT
in children with AOM serves as a moderate proxy for MEF at a very young age but becomes more
diverse at a more advanced age [61].
The most frequently observed complication of AOM in clinical practice is the spontaneous
tympanic membrane perforation (STMP) [62]. However, evidence on microbiota in children with
history of RAOM with STMP is lacking. We believe that this condition represents a distinct phenotype
of disease in otitis-prone children [63], and more effort should be directed to this category of patients,
since their clinical management is often very challenging, and the most important AOM preventive
measurements are often less effective [64–66].
Man et al. conducted a study on 94 children with tympanostomy tubes who suffered from
ear discharge. In this case, authors observed a substantial concordance between paired NP and
MEF microbiota, thus supporting the pathogen reservoir hypothesis: in particular, Pseudomonas
aeruginosa, Staphylococcus aureus, Streptococcus pyogenes, Turicella otitidis, Klebsiella pneumoniae,
and Haemophilus spp. were correlated between these two sites. Moraxella spp., Streptococcus pneumoniae,
and Corynebacterium/Dolosigranulum were predominant in NP rather than in MEF, confirming their
role as keystone bacteria of the URT; by contrast, Turicella, P. aeruginosa and S. aureus were strongly
associated to MEF. Of interest, abundance of Corynebacterium and Dolosigranulum in NP related to
a shorter course of the disease and better clinical outcomes [67].
Evidence available on AOM display that Dolosigranulum and Corynebacterium might act as potential
keystone taxa in the URT, as they have been associated to a healthy status and to a lower colonization
rate by otopathogens such as S. pneumoniae. Moreover, studies conducted on MEF identify A. otitidis
and T. otitidis as possible novel otopathogens, although the theme of sample contamination from
the EAC deserves major clarification.
An overview on microbiome study in AOM previously discussed is reported in Table 2.
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Table 2. Overview of investigations on microbiota and acute otitis media discussed in this review.
Title (Year of Publication)
[Ref] Study Design N. of Subjects Age Site of Investigation Main Findings
Microbial Communities of
the Upper Respiratory Tract
and Otitis Media in Children
(2011)
[20]
Comparison of NP microbial
communities in children with and
without OM
108
(25 with AOM;
83 without AOM)
6–78 m NP
• Microbial communities with S. pneumoniae were
significantly less diverse and less even
• Higher relative abundance of Corynebacterium
and Dolosigranulum, in addition to
Propionibacterium, Lactococcus, and Staphylococcus,
was associated with a lower incidence of
pneumococcal colonization and lower risk
of AOM
Nasopharyngeal Microbiota
in Infants with Acute Otitis
Media (2012) [44]
Comparison of NP microbial
communities in children with and
without OM
163
(153 with AOM;
10 without AOM)
<2 y NP
• NP bacterial density was lower during an AOM
episode in comparison to health
• Otopathogens predominated over commensal
families during AOM
Upper Respiratory Tract
Microbial Communities, Acute
Otitis Media Pathogens,
and Antibiotic Use in Healthy
and Sick Children (2012) [19]
Comparison of NP microbial
communities in healthy children
vs. children with URTI with and
without concurrent AOM
240
(73 healthy subjects;
95 subjects with URTI without
concurrent AOM;
72 subjects with URTI with
concurrent AOM)
6 m–3 y NP
• Lower diversity was associated with a higher
colonization rate by S. pneumoniae, H. influenzae,
and M. catarrhalis
• Biodiversity levels were significantly higher
in healthy children than during disease
• Children with antibiotic use in the past 6 months
and a higher abundance of Lactococcus and
Propionibacterium had a lower risk of AOM
• Children with no antibiotic use in the past 6
months, a low abundance of Streptococcus and
Haemophilus, and a high abundance of
Corynebacterium and Dolosigranulum had a lower
risk of AOM
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Table 2. Cont.
Title (Year of Publication)
[Ref] Study Design N. of Subjects Age Site of Investigation Main Findings
Nasopharyngeal microbiota
in infants and changes during
viral upper respiratory tract
infection and acute otitis media
(2017) [45]
NP microbiota analysis of
children followed from near birth
for the first 12 months of life or
until the occurrence of the first
AOM episode.
NP swabs collected monthly or
during each URTI or
AOM episode.
139 patients (971 samples) <1 y NP
• Bacterial diversity was lower in culture-samples
positive for S. pneumoniae and H. influenzae
compared to cultured-negative samples
• Otopathogen colonization was related to higher
incidence of URTI
• Higher abundance of otopathogens and lower
abundance of Pseudomonas, Myroides, Yersinia,
and Sphingomonas during URTI and AOM
• Higher otopathogen abundance during
symptomatic viral infection but not during
asymptomatic infection
• An unstable microbiota during URTI and
the predominance of otopathogens was
associated with a higher risk of transition from
URTI to AOM
The Adenoid Microbiome
in Recurrent Acute Otitis Media
and Obstructive Sleep Apnea
(2017) [58]
Comparison of adenoid
microbiota in subjects undergoing
surgery for RAOM or OSA
10
(5 AOM;
5 OSA)
2–11 y Adenoid
• H. influenzae, M. catarrhalis, S. pneumoniae, P.
aeruginosa, and S. aureus were predominant
in all samples
• Relative abundance of S. pneumoniae and M.
catharralis was higher in the RAOM group
• The microbial profiles associated with RAOM
were different from, but overlapped with OSA
Next-Generation Sequencing
Combined with Specific PCR
Assays To Determine
the Bacterial 16S rRNA Gene
Profiles of Middle Ear Fluid
Collected from Children with
Acute Otitis Media (2017) [59]
ME microbiota analysis during
AOM episodes 79 subjects (90 samples) 5–42 m ME
• S. pneumoniae was detected in 31% of samples, H.
influenzae in 27%, M. catarrhalis in 20%,
Staphylococcus spp. in 23%, T. otitidis in 5.6%, A.
otitidis in 3.3%
• S. pneumoniae was the dominant pathogen in 16%
of samples, H. influenzae in 17%, M. catarrhalis
in 5.6%
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Table 2. Cont.
Title (Year of Publication)
[Ref] Study Design N. of Subjects Age Site of Investigation Main Findings
A microbiome case-control
study of recurrent acute otitis
media identified potentially
protective bacterial genera
(2018) [22]
Comparison of NP microbiota
between children undergoing
grommet insertion for RAOM
(cases) vs. healthy children
(controls);
analysis of ME and EAC
microbiota in cases
196
(93 cases;
103 controls)
<5 y
NP
ME
EAC
• Significantly higher abundance of
Corynebacterium and Dolosigranulum was
detected in NP of controls in comparison to cases
• Paired NP and ME were not highly concordant:
Alloiococcus, and Turicella were abundant in ME
and EAC of cases and almost absent in NP of
both groups
• Gemella and Neisseria were typical of the NP
in cases prevalent in the middle ear
Comparative Analysis of
Microbiome in Nasopharynx
and Middle Ear in Young
Children with Acute Otitis
Media (2019) [60]
Comparison of NP microbiota 1
to 3 weeks prior to onset of AOM
vs. at onset of AOM;
comparison of NP and ME
microbiome during AOM
6 6–24 m NPME
• Significantly higher abundance of A. otitidis
detected in MEF during AOM compared to NP
in health and disease
• NP microbiome during health had a significantly
higher diversity than during AOM
Age-Dependent Dissimilarity of
the Nasopharyngeal and
Middle Ear Microbiota
in Children with Acute Otitis
Media (2019) [61]
NP microbiota analysis
during AOM;
Paired NP and ME microbiota
analysis in children with STMP
286
(42/286 MEF from STMP) 0–6 y
NP
ME
• Alpha and beta diversity levels were strictly
related to age: older children had a higher
richness and more personalized bacterial profiles
• NP and MEF microbiome were concordant when
MEF was dominated by S. pyogenes, H. influenzae,
or S. pneumoniae
Respiratory Microbiota Predicts
Clinical Disease Course of
Acute Otorrhea in Children
with Tympanostomy Tubes
(2019) [67]
Paired analysis of NP and ME
microbiota in children with
otorrhea on tympanostomy tubes
94 <5 y NPME
• Microbiota composition of NP and ME differed
significantly, although paired NP and ME
samples were more similar than
unpaired samples
• P. aeruginosa, S. aureus, S. pyogenes, T. otitidis, K.
pneumoniae, and Haemophilus spp. were
correlated between NP and ME
• Moraxella spp., S. pneumoniae,
and Corynebacterium/Dolosigranulum were
predominant in NP than in MEF
• Turicella, P. aeruginosa, and S. aureus were
strongly associated to ME
• Higher abundance of Corynebacterium and
Dolosigranulum in NP related to better
clinical outcomes
AOM: Acute otitis media. OSA: Obstructive Sleep Apnea. RAOM: Recurrent Acute Otitis media. EAC: External Auditory Canal. NP: Nasopharynx. STMP: Spontaneous Tympanic
Membrane Perforation. ME: Middle Ear. MEF: Middle Ear Fluid. URTI: Upper Respiratory Tract Infection.
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5. Otitis Media with Effusion
Otitis media with effusion (OME) is defined as the presence of middle ear fluid without signs or
symptoms of acute infection. It is defined chronic otitis media with effusion (COME) whether it persists
for more than 3 months [10].
The first study on this topic with a high-throughput molecular approach was conducted by
Liu et al., through the investigation of the microbiota of middle ear, adenoid, and tonsils in an 8-year
old child with chronic middle ear effusion undergoing adenotonsillectomy and bilateral tympanic
tube insertion. Middle ear microbiota was dominated by Pseudomonadaceae, and tonsil microbiota
showed a predominance by Streptococcaceae; adenoid microbiota was the most complex, including
Pseudomonadaceae, Streptococcaceae, Fusobacteriaceae, and Pasteurellaceae, and shared microorganisms
found both in tonsils and middle ear, supporting the hypothesis that the adenoid pad could act
as a reservoir for both of these sites [68].
Relevant new insights on OME were subsequently provided in an Australian study analyzing
NP swabs, MEF, and adenoid specimens from 11 indigenous children undergoing surgery: MEF
microbiome was characterized by low diversity indices and predominance of a single bacteria, in most
cases A. otitidis, H. influenzae, or Streptococcus spp. In particular, A. otitidis was the most common
taxa in MEF and was not detected in any NP or adenoid samples. Thus, authors speculated that its
origin from NP was unlikely and that it could represent a typical microorganism of the ME niche;
however, as A. otitidis is a known commensal of the ear canal [69], further studies were warranted
to understand its role and the influence of the ear canal flora, especially in children who suffer from
recurrent tympanic membrane perforations [70].
Fago-Olsen et al. analyzed microbiota of palatine tonsils and adenoids from children undergoing
surgery for adenoid/tonsillar hyperplasia vs. subjects undergoing surgery for secretory otitis
media (SOM), showing that several microorganisms were occasionally co-detected in both sites,
but H. influenzae, S. pneumoniae, and M. catarrhalis were significantly more abundant in the adenoids
and almost absent from palatine tonsils, indicating that adenoids but not palatine tonsils could act
as main reservoir of pathogens leading to OM. However, it should be noted that this study did not
include MEF microbiota analysis [71].
Data concerning dissimilarities between NP and MEF microbiome were provided in a following
investigation including 10 children undergoing adenotonsillectomy and grommet insertion for OME.
The authors reported that adenoid and tonsil microbiota shared a higher similarity than adenoid and
ME, thus questioning the PRH in OME. According to previous findings, Alloiococcus and Turicella were
detected only in MEF samples; however, the most abundant genera in middle ear were Fusobacterium
and Staphylococcus [72]. These data were subsequently confirmed in an investigation by Ari et al.
on a larger population of children with OME: ME microbiome was characterized by a significant
predominance of Alloicoccus otitidis (44%), Turicella otitidis (6%), and Staphylococcus auricularis (3%),
while adenoid harbored a high relative abundance of Rothia, Staphylococcus, and Granulicatella. As for
diversity indices, no significant dissimilarities in alpha-diversity were found between MEF and adenoid
niches [73].
The potential role of A. otitidis as a key bacteria of the ME was confirmed in an investigation by
Chan et al., through the analysis of paired MEF samples and adenoid swabs from children undergoing
grommet insertion for OME and of adenoid swabs from healthy subjects. Data evidenced a different
composition in microbial communities between paired MEF and adenoid, as 13 of the 17 most abundant
genera showed a statistically significant difference in relative abundance. In particular, A. otitidis was
the predominant OTU in MEF (23% mean relative abundance), while it was almost absent in adenoid
samples (<1% relative abundance). Interestingly, this taxa was found in greater abundance in children
with unilateral effusion. Authors postulated that the dissimilarities between the MEF and adenoid
microbiota could question the PRH in children with OME: Adenoidal hypertrophy and Eustachian
tube dysfunction predispose to OME, but subsequent modifications in the ME environment determine
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an unbalance in the local flora with the predominance of a certain microorganism that can potentially
lead to acute disease [74].
Similarly, caution when using nasopharyngeal microbiota as a proxy for ME was warranted by
Boers et al. in an investigation comparing NP and ME microbiota in children with gastro-esophageal
reflux (GER) associated OM vs. children who suffered from OM without GER. Authors enrolled
30 subjects with RAOM, COME or both undergoing tympanostomy tube placement, identifying
Alloiooccus spp. and Turicella spp. as the most abundant taxa in MEF while absent in NP samples.
As for GER, no apparent effects were found on the NP and ME microbiota in the two groups [75].
A more recent investigation conducted in a tertiary hospital in China analyzed ME and adenoid
microbiota from children undergoing surgery for OME and adenoid hypertrophy (AH) vs. adenoid
microbiota from subjects without ear disease undergoing adenotonsillectomy for OSA. ME was
dominated by Haemophilus (14.75%), followed by Staphylococcus (9.37%) and Halomonas (7.85%);
moreover, in contrast with previous findings, Alloiococcus otitidis had low relative abundance in this
site (3.75%), and Turicella was not reported at all among the most abundant genera: Authors stated
that these differences with previous findings could be attributable to variation in sampling methods,
sample size or geographical location. Four taxa were found to be significantly differentially abundant
between ME and adenoid in OME group (Streptococcus, Neisseria, Alloprevotella, and Actinobacillus),
while the classical otopathogens were commonly found both in adenoid and ME in all OME patients.
Adenoid microbiota in controls was composed predominantly by Haemophilus (15.96%), Streptococcus
(13.33%), and Moraxella (12.28%); however, no significant differences in relative abundances of these
genera were found in adenoids of OME patients vs. controls. According to this data and to previous
findings, authors concluded that the dissimilarities in microbial compositions between these two niches
challenge the PRH in OME [76].
The potential reservoirs for ME microbiome in children with OME were investigated by Chan et al.:
MEF analysis showed similar results to the previous studies, as ME was dominated by A. otitidis,
followed by Haemophilus, Moraxella, Staphylococcus, and Streptococcus; the EAC microbiome was mostly
constituted by A. otitidis, Staphylococcus and Pseudomonas with rare otopathogens, whereas adenoid
microbiome was composed prevalently by otopathogens, with rare EAC genera such as Alloiococcus.
Basing on this data and on the previous study, authors concluded that both EAC and NP could
act as a reservoir for the middle ear in children with OME. However, as bacterial translocation
across an intact tympanum has not been demonstrated yet, a membrane perforation (spontaneous
or iatrogenic) is probably needed to allow bacteria to translocate from EAC to ME. Unfortunately,
a history of previous perforations in this cohort is not available [77].
Another pivotal genera in OME pathogenesis is Haemophilus, as highlighted in a study on
ME microbiome in 55 children with chronic middle ear effusion: the most abundant genera were
Haemophilus (relative abundance 22.54%), Moraxella (11.11%), Turicella (7.84%), Alcaligenaceae (5.84%),
Pseudomonas (5.40%), and Alloiococcus (5.08%). Moreover, children were grouped by age, hearing loss,
and mucin type expression in MEF: Haemophilus was significantly more abundant in children with
hearing loss and was associated to MEF containing MUC5B and MUC5A, suggesting a correlation
between hearing loss and mucin content in relationship to Haemophilus abundance [78].
Kolbe et al. provided data on 50 children undergoing tube placement for COME with a more
detailed taxonomic resolution. In contrast to previous data that observed a predominance by
Alloiococcus, Moraxella, or Haemophilus in MEF, in this study, microbial communities were highly
variable, and the classical otopathogens were absent in about half of the samples. Moreover, authors
compared subject based on whether they had a history of lower airway disease (asthma or bronchiolitis):
Haemophilus, Staphylococcus, and Moraxella were significantly more abundant in children with lower
airway diseases, while Turicella and Alloiococcus were less prevalent; in addition, ME microbial
communities in children with history of asthma/bronchiolitis were significantly less diverse than
children who had only COME [79].
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Nasopharyngeal microbiome is less diverse in children suffering from OME than in controls,
as highlighted by two case-control studies [80,81]. In particular, Walker et al. showed that the nasal
microbiome in children with OME is composed of a higher abundance of pathogens, with a lower
abundance of commensals as alpha-hemolytic Streptococci and Lactococcus. Moreover, cluster analysis
revealed that profiles dominated by Corynebacterium, Streptococcus, or Moraxella were associated
with COME, while healthy children had a more mixed bacterial profile with higher abundance of
commensals [81].
In conclusion, investigations on OME discussed above confirm the role of the known otopathogens,
in particular H. influenzae, as the predominant taxa in MEF during disease. Moreover, as previously
described for AOM, A. otitidis and T. otitidis are frequently identified as abundant members of the ME
microbiota. Studies have so far failed to define the possible reservoir for ME microbiome, and it is not
possible to exclude a sample contamination from the EAC, especially in a low biomass environment as
the ME. Concerning this theme, we believe that further studies should also be focused on patients with
a history of tympanic membrane perforation, which might be the entryway for microorganisms that
colonize the EAC.
An overview on microbiome study in OME previously discussed is reported in Table 3.
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Table 3. Overview of investigations on microbiota and otitis media with effusion discussed in this review.
Title (Year of Publication)
[Ref] Study Design N. of Subjects Age Site of Investigation Main Findings
The Otologic Microbiome: A
Study of the Bacterial
Microbiota in a Pediatric
Patient with Chronic Serous
Otitis Media Using 16SrRNA
Gene-Based Pyrosequencing
(2011) [68]
Microbiota analysis in ME, adenoid,
and tonsil specimens from one
pediatric patient with chronic
serous otitis media undergoing
adenotonsillectomy and bilateral
tympanic tube insertion
1 8 y
Adenoid
ME
Tonsil
• Pseudomonadaceae were predominant in ME
• Streptococcaceae were predominant in tonsil
• Adenoid microbiota included multiple
predominant bacteria: Pseudomonadaceae,
Streptococcaceae, Fusobacteriaceae,
and Pasteurellaceae
• Adenoid microbiota shared bacteria found both
in tonsils and middle ear
The microbiome of otitis media
with effusion in Indigenous
Australian children (2015) [70]
MEF, NP, and adenoid microbiota
analysis in children undergoing
surgical treatment for OME
11 3–9 y
NP
Adenoid
ME
• ME microbiota was dominated by A. otitidis, H.
influenzae, or Streptococcus spp.
• A. otitidis was the most common OTU in MEF
and was not detected in any NP or
adenoid samples
• Streptococcus spp., H. influenzae, and M.
catarrhalis were common to all sample types
The Microbiome of Otitis Media
with Effusion (2016) [74]
ME and adenoid microbiota
analysis in children undergoing
adenoidectomy with ventilation
tube insertion for chronic OME.
Adenoid microbiota analysis from
healthy subjects enrolled as controls
33
(23 subjects with OME;
10 healthy controls)
OME group:
1–8 y
Control group:
1–12 y
ME
Adenoid
• ME microbiota was dominated by A. otitidis (23%
mean relative abundance), Haemophilus (22%),
Moraxella (5%), and Streptococcus (5%)
• Different microbial composition between paired
MEF and adenoid: 13/17 of the most abundant
genera showed a statistically significant
difference in relative abundance
• A. otitidis was the predominant OTU in MEF
(23% mean relative abundance), while it was
almost absent in adenoid samples (<1%
relative abundance)
The Relationship of the Middle
Ear Effusion Microbiome to
Secretory Mucin Production
in Pediatric Patients with
Chronic Otitis Media (2016) [78]
Microbiota analysis and mucin
detection in MEF collected from
children undergoing myringotomy
with tympanostomy tube
placement for chronic OME
55 3–176 m ME
• The most abundant genera were Haemophilus
(relative abundance 22.54%), Moraxella (11.11%),
Turicella (7.84%), Alcaligenaceae (5.84%),
Pseudomonas (5.40%), and Alloiococcus (5.08%)
• Haemophilus was significantly more abundant
in children with hearing loss and was associated
to samples containing secretory mucins as
MUC5B and MUC5A
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Table 3. Cont.
Title (Year of Publication)
[Ref] Study Design N. of Subjects Age Site of Investigation Main Findings
Identification of the Bacterial
Reservoirs for the Middle Ear
Using Phylogenic Analysis
(2017) [77]
ME and EAC microbiota analysis
in children undergoing surgery for
OME.
Adenoid pad and ME microbiota
analysis data were included from
a previous study
18 1–14 y MEEAC
• The MEF microbiota was dominated by A.
Otitidis (37.5%), Haemophilus (14.4%), Moraxella
(10.0%), Staphylococcus (8.2%), and Streptococcus
(3.8%)
• The EAC had a high abundance of Alloiococcus
(58.0%), Staphylococcus (20.8%), and Pseudomonas
(3.2) with rare otopathogens
• The adenoid microbiota had a high abundance of
otopathogens with rare EAC genera: Alloiococcus
(0.1% vs. 28.9%), Haemophilus (25.2% vs. 18.2%),
Staphylococcus (0.2% vs. 10.8%), Streptococcus
(12.7% vs. 4.2%), and Pseudomonas (0
vs.2.1%, respectively)
Pathogen reservoir hypothesis
investigated by analyses of
the adenotonsillar and middle
ear microbiota (2018) [72]
Adenoid, middle ear, and tonsil
microbiota analysis in children
undergoing surgical treatment for
OME
10 5–10 y
Adenoid
ME
Tonsil
• The most abundant genera in all sites were
Fusobacterium, Haemophilus, Neisseria,
and Porphyromonas
• Higher proportion of Haemophilus and Moraxella
in the adenoid than ME
• Alloiococcus and Turicella were detected only
in MEF samples
• Adenoid and tonsil microbiota shared a higher
similarity than adenoid and ME
Characterization of
the nasopharyngeal and middle
ear microbiota
in gastroesophageal
reflux-prone versus
gastroesophageal reflux
non-prone children (2018) [75]
Analysis of NP and ME microbiota
in children suffering from
GER-associated OM vs. OM only
undergoing surgical treatment for
RAOM, COME, or both
30
(9 subjects with
GER-associated OM;
21 subjects with OM without
GER)
GER group 1.3–6 y
No GER group
0.8–12–8 y
NP
ME
• No effect of GER on NP and ME microbiota
in the two groups
• Alloiococcus spp. and Turicella spp. were the most
common taxa in MEF and were not detected
in any NP swab
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Table 3. Cont.
Title (Year of Publication)
[Ref] Study Design N. of Subjects Age Site of Investigation Main Findings
The Adenoids but Not
the Palatine Tonsils Serve as a
Reservoir for Bacteria
Associated with Secretory Otitis
Media in Small Children (2019)
[76]
Adenoid and tonsillar microbiota
analysis in children undergoing
surgical treatment for hyperplasia
of adenoids/tonsils without
infection (HP group) vs. children
undergoing surgery for SOM
28 (112 samples)
(14 subjects in HP group;
14 subjects in SOM group)
HP group
24–65 m
SOM group
15–59 m
Adenoid
Tonsils
• The number of OTUs detected in the adenoids
from the HP group was significantly lower
compared to the number detected in adenoids
from SOM group
• Streptococcus was the most abundant genus
(average 25.6%) followed by Fusobacterium
(11.1%) and Haemophilus (10.3%)
• Microbial communities were significantly
different between the adenoid and tonsil samples
• S. pneumoniae was significantly more abundant
in the adenoids of HP group compared to
adenoids of SOM group
• Fusobacterium nucleatum was abundant
in the adenoids of HP group but was almost
in the adenoids of SOM group
• The classical otopathogens (H. influenzae, S.
pneumoniae, and M. catarrhalis) were significantly
more abundant in the adenoids than
in the tonsils
Nasal microbial composition
and chronic otitis media with
effusion: A case-control study
(2019) [81]
Comparison of nasal microbiota
between children undergoing
surgery for COME vs. healthy
subjects
178
(73 cases;
105 controls)
Case group: mean
age 47.5 m
Control group:
mean age 49.6 m
Nasal (anterior nares)
• Children with COME had lower diversity than
healthy controls
• Children with COME had a higher abundance of
otopathogens and lower abundance of
commensals as Haemolytic Streptococci and
Lactococcus
• Profiles that were Corynebacterium-dominated or
Moraxella-dominated were associated with COME
Altered Middle Ear Microbiome
in Children with Chronic Otitis
Media with Effusion and
Respiratory Illnesses (2019) [79]
Comparison of ME microbiota
children with chronic OME and
history of lower airways disease
(asthma or bronchiolitis) vs.
children with chronic OME without
history of lower airways disease
50 (13 with history of lower
airway disease) 3–176 m ME
• The ME microbiome was significantly less
diverse in children with lower airway disease
• Haemophilus, Staphylococcus, and Moraxella were
significantly more abundant in ME of children
with lower airways disease
Analysis of the Microbiome
in the Adenoids of Korean
Children with Otitis Media
with Effusion (2019) [80]
Adenoid microbiota comparison
between children undergoing
surgery for OME vs. children
without undergoing surgery for
obstructive symptoms
32
(16 subjects with OME;
16 subjects without OME)
19 m–15 y Adenoid
• Diversity levels were lower in the OME group
• Haemophilus was the most abundant
in the OME group
• Prevotella, Delftia, and Corynebacterium were
the dominant genera in the OME group
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Table 3. Cont.
Title (Year of Publication)
[Ref] Study Design N. of Subjects Age Site of Investigation Main Findings
The bacteriome of otitis media
with effusion: does it originate
from the adenoid? (2019) [73]
Adenoid and ME microbiota
analysis in children undergoing
surgery for OME
25 1.5–9 y AdenoidME
• ME microbiome was dominated by A. otitis
(44%), T. otitidis (6%), and S. auricularis (3%)
• Adenoid microbiome was dominated by Rothia,
Staphylococcus, and Granulicatella
• No statistically significant difference in alpha
diversity between the two niches; adenoid
samples clustered in the beta diversity graph
The microbiomes of adenoid
and middle ear in children with
otitis media with effusion and
hypertrophy from a tertiary
hospital in China (2020) [76]
Adenoid and ME microbiota
analysis in children undergoing
surgical treatment for OME vs.
adenoid microbiota analysis
in children undergoing surgery for
OSA without ear disease
30
(15 in OME group;
15 in OSA group)
OME group
60–108 m
OSA group
8–96 m
Adenoid
ME
• ME in OME was dominated by Haemophilus
(14.75%), Staphylococcus (9.37%), and Halomonas
(7.85%)
• Low abundance of A. otitis (3.75%) in ME
in OME group
• Adenoid microbiota in OME group was
dominated by Haemophilus (21.87%),
Streptococcus (19.65%), and Neisseria (5.8%)
• Adenoid microbiota in OSA was dominated by
Haemophilus (15.96%), Streptococcus (13.33%),
and Moraxella (12.28%)
• No significant differences in alpha-diversity
between ME and adenoids in OME group
• Beta diversity analyses showed that
the microbiome structure of ME was dissimilar
the adenoid one in OME patients: taxa found to
be significantly differentially abundant between
these two sites were Streptococcus, Neisseria,
Alloprevotella, and Actinobacillus
OME: Otitis Media with Effusion. COME: Chronic Otitis Media with Effusion. NP: Nasopharynx. ME: Middle Ear. MEF: Middle Ear Fluid. GER: Gastro-esophageal reflux. RAOM:
Recurrent acute otitis media. SOM: Secretive otitis media. EAC: External auditory Canal. OTU: Operational Taxonomic Unit. OSA: Obstructive sleep apnea.
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6. Chronic Suppurative Otitis Media
Chronic suppurative otitis media (CSOM) is defined as a chronic inflammation of the middle
ear and mastoid cavity, with recurrent or persistent ear discharge through a non-intact tympanic
membrane [10]. Less evidence is available on microbial communities in pediatric patients suffering
from this condition.
Neef et al. compared 24 children with CSOM undergoing mastoid surgery to 22 healthy controls
undergoing ear surgery for other conditions as cochlear implantation or benign brain tumor removal.
Microbiota analysis and conventional culture were performed on swabs collected from middle ear
and mastoid cavity during surgery. Authors did not observe a typical bacterial profile associated to
CSOM, but highlighted the limits of the conventional culture-based approach, as no bacteria were
detected by culture in healthy subjects. By contrast, molecular analysis detected potential pathogens
as Staphylococcus, Pseudomonas, and Haemophilus even in healthy controls. As for diversity, authors
observed a major inter-personal difference among CSOM patients, whereas this finding was not
observed for controls. This data supported the hypothesis that microbial communities’ disruption and
dysbiosis could be implicated in CSOM pathogenesis [82].
These dissimilarities among patients suffering from CSOM are age-related, as reported by
Minami et al. In this investigation, middle ear swabs were collected during surgery in pediatric and
adult patients undergoing tympanoplasty for wet or dry COM vs. subjects undergoing surgery from
other conditions than otitis media. Proteobacteria was the predominant phylum detected in normal
subjects, both adults and children. However, the normal middle ear microbiota differed significantly
according to age: Authors concluded that this dissimilarity between adults and children could be
related to the higher incidence of Staphylococcus (Firmicutes phylum) in adults. Subjects with active
inflammation and wet COM had a lower abundance of Proteobacteria and a higher incidence of
Firmicutes: Authors warranted this finding to be considered in the pathogenesis of active inflammation
in COM, in relation to the potential penetration of several exogenous pathogens through a chronic
perforation. On the other hand, microbiome of dry COM was not significantly different from normal
middle ear [83].
Santos-Cortez et al. previously performed an investigation comparing ME and EAC microbiome
in 16 indigenous Filipino subject with chronic tympanic membrane perforation, showing that
the microbial communities between these two niches were similar, probably due to a cross-contamination
process through the perforated eardrum. Moreover, authors investigated microbiota composition
in subjects who were carrier of the A2ML1 gene, which encodes an alpha-2 macroglobulin-like
1 protein, previously identified as a genetically determined risk factor for of otitis media [84].
Authors detected a higher relative abundance of Fusobacterium, Porphyromonas, Peptostreptococcus,
Parvimonas, and Bacteroides in the ME of A2ML1-carrier patients, while Alloiococcus, Staphylococcus,
Proteus, and Haemophilus were more abundant in ME of non-carrier subjects. Authors speculated
that the expected loss-of-function of A2ML1 protein could influence ME microbiota composition
promoting survival and growth of specific microorganism. This findings warrant further investigations
on the relationship between host genotype and microbiota in OM [85].
Evidence on CSOM is lacking and does not show peculiar features of microbial communities
in this OM phenotype. Moreover, investigations discussed above include both adults and children,
thus it is difficult to draw any general conclusion in the pediatric population. The penetration of
microorganisms residing in the EAC from the chronic tympanic membrane perforation has been
considered in the pathogenesis of the active inflammation in CSOM, but further studies are needed to
define with major detail this aspect.
An overview on microbiome study in CSOM previously discussed is reported in Table 4.
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Table 4. Overview of investigations on microbiota and chronic suppurative otitis media discussed in this review.
Title (Year of Publication)
[Ref] Study Design N. of Subjects Age Site of Investigation Main Findings
Molecular Microbiological
Profile of Chronic Suppurative
Otitis Media (2016) [82]
Comparison of ME and
mastoid microbiota
in patients with CSOM
undergoing surgery vs.
healthy controls
46
(24 subjects with CSOM;
22 healthy subjects)
6 m–85 y MEMastoid cavity
• No typical bacterial profile associated to CSOM
• No bacteria were detected by culture in healthy
subjects, while molecular analysis detected
potential pathogens such as Staphylococcus,
Pseudomonas, and Haemophilus
• Inter-personal difference in diversity levels
among CSOM patients but not among controls
Microbiomes of the Normal
Middle Ear and Ears with
Chronic Otitis Media (2017) [83]
ME microbiota analysis
in patients undergoing
tympanoplasty for wet or
dry COM vs. subjects
undergoing surgery from
other conditions than
otitis media
155
(67 healthy subjects;
44 subjects with COM
without active infection;
44 subjects with COM
with active infection)
1–84 y ME
• The normal middle ear microbiota differed
significantly according to age: in particular,
a higher incidence of Staphylococcus (Firmicutes
phylum) was detected in adults
• Microbiome of dry COM was not significantly
different from normal middle ear
• Lower abundance of Proteobacteria and higher
incidence of Firmicutes in subjects with active
inflammation and wet COM
Middle ear microbiome
differences in indigenous
Filipinos with chronic otitis
media due to a duplication
in the A2ML1 gene (2016) [85]
ME and EAC microbiota
analysis in indigenous
Filipinos with chronic
otitis media; comparison
of microbial communities
in subjects carriers of
A2ML1 variant vs. non
carrier subjects
16
(11 subjects carriers of
A2ML1 variant)
4–24 y MEEAC
• Microbial communities between ME and EAC
were similar
• Higher relative abundance of Fusobacterium,
Porphyromonas, Peptostreptococcus, Parvimonas,
and Bacteroides in the ME of
A2ML1-carrier patients
• Higher relative abundance of Alloiococcus,
Staphylococcus, Proteus, and Haemophilus in ME of
non-carrier subjects
CSOM: Chronic Suppurative Otitis Media. COM: Chronic Otitis Media. ME: Middle Ear. EAC: External auditory canal.
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7. Probiotic Therapy
Prevention of OM in children represents one of the most difficult aspects in the clinical management
of these patients.
Restoration of dysbiosis through administration of probiotic strains is a preventive strategy that
has gained major clinical and scientific interest in recent years in several diseases, including otitis media.
Probiotics are defined as “live microorganisms that, when administered in adequate amounts,
confer a health benefit on the host” [86]. The introduction of high-throughput sequencing methods has
allowed the investigation of entire bacterial communities and the identification of microorganisms
associated to health status in various conditions.
As previously discussed, evidence on microbiota in children suffering from OM suggest that
Corynebacterium spp. and Dolosigranulum pigrum are potential keystone taxa in the URT; thus, major
interest has been directed towards these two microorganisms and their potential use as probiotics.
A detailed discussion of evidence available on probiotic therapy in OM goes beyond the scope of
this review, as it has been recently extensively reviewed elsewhere.
A recent review by van den Broek et al. described novel insights on probiotic therapy in OM [87].
Basing on Koch’s postulates, authors introduced the “probiotic postulates” to define the ideal probiotic
strain to be used in clinical practice: The microorganism can be found in high abundance in health
status and decreased abundance during disease; the microorganism can be isolated from a healthy
organism and grown in pure culture; the cultured organism should promote health when introduced
into a diseased organism; it should be possible to re-isolate these microorganisms as identical to
the original agent from the healthy host. According to available evidence and to this postulates, authors
identified Dolosigranulum as a prime candidate for the development of probiotic therapy.
However, current knowledge is still not sufficient to define probiotic efficacy for preventing OM.
A recent systematic review included 13 studies on this subject, concluding that available evidence on
probiotics use for the prevention of AOM is limited; among the various formulations, possible benefit
could derive from nasal administration [88].
The most important limitations in evidence on this topic are poor to moderate quality of
the investigations and great heterogeneity in route of administration (oral vs. intranasal), probiotic
strains included in formulations, duration of therapy, and outcome measures.
8. Conclusions
The introduction of the modern molecular techniques and the subsequent investigations on
microbial communities in the human organisms have changed our conceptions of health and disease
and our approach to infectious conditions.
It is indeed well known that health and disease status are not merely determined by the presence
or the absence of a pathogen but depend on a complex balance established among pathogens, resident
microbiota, and host immune response.
Investigations previously described in this review have provided novel insights on the pathogenesis
of middle ear diseases and led to the identification of both possible new causative agents and of
potential protective bacteria, showing that imbalances in bacterial communities of the URT and ME
could influence the natural history of otitis media in children.
However, scientific data on this topic are often difficult to compare because of methodological
differences in specimen collection and analysis, in the site of investigation, and in data reporting.
Moreover, a lack of standard diagnostic criteria for OM across countries often influences the enrollment
phase and contributes to increase the heterogeneity among populations under investigation.
Another element that complicates data interpretation and deserves standardization is the use
of different databases during OTUs assignment. This is a relevant issue that should be taken into
consideration for two main reasons: different databases might lead to heterogeneous results; some
taxa could be misclassified with certain databases, as reported for A. otitidis and T. otitidis [89].
We believe that future investigation should be focused on the following aspects:
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• Defining standard criteria of specimen collection, analysis, and data reporting, in order to facilitate
data comparison across studies;
• Deepening our knowledge on the impact of various exogenous factors that have been less explored,
such as active/passive smoking, vaccines, and viral infections;
• Confirming the role of Corynebacterium and/or Dolosigranulum as keystone taxa, in order to evaluate
their possible use as probiotics;
• Understanding the development of URT and ME microbiota at different ages, in order to identify
a potential “window of opportunity” in which therapeutic interventions as probiotic administration
could be more effective, before the establishment of a stable microbial community that could be
modulated with difficulty;
• Investigating the concordance between NP and ME microbiota, in order to better define the role
of adenoid pad as a proxy for ME;
• Providing data on microbial communities in ME, which is no longer considered a sterile site;
• Defining with major detail the features of NP and ME microbial communities in different OM
phenotypes, in particular in children with recurrent STMP.
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